Cluster 19 was CD159c+ and distinct from adaptive NK cells prevalent in the periphery (cluster 21) or HD liver (cluster 12) as they expressed high levels of CD57 and CD314 and higher levels of the checkpoint inhibitory molecule TIGIT and the inhibitory receptor CD85j as compared to cluster 21. The gene discussed is KLRC2; the disease is Huntington disease.